跳至主要内容
临床试验/NCT03115047
NCT03115047已完成3 期

Traitement Des Frissons Lors de la césarienne Sous anesthésie péridurale Durant le Travail - un Essai Clinique randomisé Comparant la dexmédétomidine et la mépéridine

Centre hospitalier de l'Université de Montréal (CHUM)1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年5月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Stop time

研究概览

简要总结

Comparing two treatments for shivering after cesarean delivery for labor dystocia under epidural anesthesia.

详细描述

It is a double blinded randomized control trial.

Study population: parturients undergoing a cesarean delivery for labor dystocia under epidural anesthesia experiencing shivering grade III or IV on the standardized shivering scale of Crossley and Mahajan

Experimental group: dexmedetomidine 0.35 mcg/kg IV in 2 minutes

Control group: meperidine 0.35 mg/kg IV in 2 minutes

Primary outcome : Time to stop level III and IV shivering on the Crossley and Mahajan standardized shivering scale after the administration of the study drug

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Double-blinded randomized study: meperidine and dexmedetomidine will be prepared at the hospital pharmacy in a 10 mL seringue with equivalent dilution in order to gave mL/kg.

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Term > 37 weeks
  • American Society of Anesthesiologists Physical Status (ASA PS) I, II
  • Weight < 115 kg
  • Functional epidural in situ
  • In labor requiring cesarean delivery
  • Class III or IV shivering on the Crossley and Mahajan standardized shivering scale between five minutes after the baby's birth to the end of the cesarean section

排除标准

  • Refusal of the patient and/or the anesthesiologist
  • Misunderstanding of the protocol
  • Known allergy or contraindication to one of the study drugs
  • Emergency cesarean delivery
  • American Society of Anesthesiologists Physical Status III, IV, V
  • Severe heart, liver or kidney disease,
  • Preeclampsia
  • Patient taking monoamine oxydase inhibitors
  • Sleep apnea
  • General anesthesia

研究组 & 干预措施

dexmedetomidine

Experimental

Unique dose of dexmedetomidine injection:

  • intravenous injection
  • 0.35 mcg/kg
  • in two minutes
  • if shivering 5 minutes after delivery

干预措施: Dexmedetomidine Injection (Drug)

meperidine

Active Comparator

Unique dose of meperidine injection:

  • intravenous injection
  • 0.35 mg/kg
  • in two minutes
  • if shivering 5 minutes after delivery

干预措施: Meperidine Injection (Drug)

结局指标

主要结局

Stop time

时间窗: 15 minutes

Time to stop class III or IV shivering on the Crossley and Mahajan standardized shivering scale after the administration of the study drug (meperidine versus dexmedetomidine)

次要结局

  • incidence of adverse effects(24 hours)
  • maternal satisfaction(at 24 hours)
  • response rate(15 minutes)
  • cost benefice analysis(24 hours)

研究者

发起方
Centre hospitalier de l'Université de Montréal (CHUM)
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验